Google Inc. has said its health-care research unit, Google Life Sciences, agreed to work with European pharmaceutical company Sanofi SA on new ways to monitor and treat diabetes.
Sanofi is a leading maker of diabetes medication, as well as many other drugs.
Google’s Life Sciences division is working on small, connected medical devices to continuously collect diabetes-related data, as well as software that learns from the information to find new treatments.
Diabetes is expected to affect 592 million people world-wide by 2035, according to the International Diabetes Federation.
“With Sanofi, we can complete the picture of how diabetes unfolds and try to interrupt that development through a proactive and preventive approach,” said leader of Google Life sciences, Andrew Conrad.
He said the Sanofi partnership is the latest of several collaborations that combine expertise in medication, medical devices, software and computing infrastructure.